OBJECTIVE To describe the long-term natural history of essential thrombocythemia (ET) in
terms of life expectancy, risk of disease transformation into a more aggressive myeloid …

A total of 187 consecutive patients with essential thrombocythemia (ET) were diagnosed and
followed by our Hematology Department in the period October 1980–November 1994. The …

Background Essential thrombocythemia is a chronic myeloproliferative disorder; patients
with this disorder have a propensity to develop thrombosis, myelofibrosis, and leukemia …

Unlike the case with thrombosis, prognostic models for survival and leukemic transformation
(LT) in essential thrombocythemia (ET) are not available. Among 605 patients with ET seen …

Background Essential thrombocythemia (ET) is a clonal myeloproliferative disease
associated with thrombohemorrhagic complications and myeloid transformation to diseases …

A working diagnosis of essential thrombocythemia (ET) is made in the presence of
nonreactive thrombocytosis and after the exclusion of another chronic myeloid disorder that …

Diagnosis of essential thrombocythemia (ET) has been updated in the last World Health
Organization (WHO) classification. We developed a prognostic model to predict survival at …

The frequency of vascular events and evolution to myelofibrosis (MF) in young individuals
with essential thrombocythemia (ET) is not well known. The incidence and predisposing …

To determine the clinicohematological factors predictive for the appearance of major
vascular complications (MVC) in patients with essential thrombocythemia (ET), 148 …

In an attempt to characterise the clinical features, incidence and outcome of essential
thrombocythaemia (ET) we report our experience in a large unselected series of patients …